Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$146.67 USD
+1.39 (0.96%)
Updated May 31, 2024 03:59 PM ET
After-Market: $146.60 -0.07 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Johnson & Johnson [JNJ]
Reports for Purchase
Showing records 21 - 40 ( 499 total )
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended November 10.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 111123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended October 20.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 102123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended October 13.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 101123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 10123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended September 22.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 92123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 91123
Provider: Stock Traders Daily
Analyst: Research Department